ACHV
Achieve Life Sciences, Inc.
$6.45
+0.05 (+0.78%)
At close · Jul 6
Market Cap
$662.15M
Shares
102,659,057
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$6.45
Open$6.41
Day$6.38–6.66
52W$2.02–7.11
Avg vol 30d2.3M
Short int8.2M · 8.0% float · 6.1d
Short vol66%
Last earningsMay 12, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 12
Equibles Rating
blended score · not investment advice
Overall
Buy
Technical · trend & momentum
Strong Buy
◦
50 / 200-day cross
no cross
+
Price vs 200-day avg
+44% above
+
Price vs 50-day avg
+25% above
◦
RSI (14)
66 · neutral
+
MACD trend
positive
+
52-week position
87% · near high
Sentiment · smart money
Bullish
◦
Trend (MA cross)
50d $5 › 200d $4 — 50d above 200d
+
Institutional flow
+5% holders QoQ · +17 funds added
◦
Insider flow
No net insider activity over 90 days
−
Short interest
8.02% of float · ▲ +7.2% MoM · 6.1 days cover
◦
Volume signal
Volume near normal
+
Institution breadth
82 holders — near 3-yr high, broad support
Fundamentals
Weak
−
EPS growth
−1% Y/Y
−
Free cash flow
$-49.5M
+
Balance sheet
net cash $20.9M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
Next earnings call
Aug 9, 2026
Est · unconfirmed
· in 5 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 12, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Technicals
trend & momentum for long-term holders Strong Buy
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
+44% above
Bullish
Price vs 50-day avg
+25% above
Bullish
RSI (14)
66 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
87% · near high
Bullish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $5 › 200d $4 — 50d above 200d
Institutional flow
Accumulating
+5% holders QoQ · +17 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
8.02% of float · ▲ +7.2% MoM · 6.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
82 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $2
Now $6 · 87%
52-wk high $7
vs 200-day avg +44%
vs 50-day avg +25%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ACHV
this stock
Achieve Life Sciences, Inc.
|
$662.15M | +29.8% | — | — | 8.0% |
|
AKTX
Akari Therapeutics Plc
|
$998.08B | -5.7% | — | — | 0.0% |
|
ONC
BeOne Medicines Ltd.
|
$488.96B | +1.9% | +22179.2% | 995.1 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$134.41B | +16.8% | +46.2% | 31.4 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.33B | -15.7% | +20.8% | 16.1 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ACHV | +7.1% | +21.9% | +16.0% | -1.2% | +29.8% |
| SPY | +3.1% | -0.8% | +8.2% | +0.6% | +10.2% |
| vs SPY | +4.1% | +22.7% | +7.8% | -1.8% | +19.6% |